CD4 and anemia (phenotype): Moreover, having established that women in the advanced stage of HIV disease (CD4<200 cells/mm3) are more likely to be affected by anaemia in this study, we further report that there was no evidence of any added risk for anaemia with either of the ARV regimen (ZDV or the non ZDV containing triple ARV regimen) in women with a higher CD4 count.